[PLX] YoY Quarter Result on 30-Jun-2020 [#Q2]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
10-Aug-2020
Financial Year
2020
Quarter
30-Jun-2020 [#Q2]
Profit Trend
QoQ- -348.95%
YoY- 46.40%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 35,075 8,753 6,427 10,967 12,247 2,006 6,358 32.90%
PBT 19,647 -5,334 -11,241 -4,150 -7,743 -11,294 450 87.59%
Tax 308 -190 128 38 3 75 3,045 -31.72%
NP 19,339 -5,144 -11,241 -4,150 -7,743 -11,294 450 87.10%
Tax Rate -1.57% - - - - - -676.67% -
Total Cost 15,736 13,897 17,668 15,117 19,990 13,300 5,908 17.72%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin 55.14 -58.77 -174.90 -37.84 -63.22 -563.01 7.08 40.76%
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
EPS 0.29 -0.11 -0.25 -0.13 -0.52 -0.77 0.04 39.09%
EPS Diluted 0.21 -0.11 -0.25 -0.13 -0.52 -0.77 -0.60 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.